Medical nutrition after cholecystectomy
AbstractCholecystectomy (CE) is one of the most frequently performed surgical interventions and the main method of symptomatic gallstone disease treatment. Despite the widespread implementation of minimally invasive surgery techniques, significant proportion of patients develop spectrum of symptoms after CE. These manifestations require correction with different approaches including medical nutrition.
The aim of the research was to perform structured review of recently published data related to diet therapy and nutritional support of patients after CE.
Material and methods. A literature search was performed in PubMed/MEDLINE, EMBASE, Cyberleninka, eLibrary databases using the keywords “Cholecystectomy” in combination with “Diet”, “Medical nutrition”, “Nutritional support” and their Russian-language equivalents for the relevant databases. Correct description of interventions, analyzed outcomes, statistical processing and found effects where necessary for the inclusion to the analysis. Duplicate publications were excluded.
Results and discussion. A review of the recommendations on nutritional support after CE has been conducted, including handbooks and clinical guidelines, results of relevant clinical trials evaluating the efficacy of different measures of nutritional support. The rational of traditionally used dietary approaches for the correction of symptoms that develop after CE has been assessed, as well as recently published data on the effectiveness of nutritional support methods.
Conclusion. Disturbed regulation of bile secretion in the early CE postoperative period may support the need for limitation of fat consumption. Impaired circulation of bile acids and possible changes in the balance of intestinal microbiota may support the need for the use of prebiotics (like dietary fiber), as well as probiotics, especially when antibiotic treatment was administrated for the patient. These interventions may be important from the viewpoint of prevention of late complications after CE.
Keywords:cholecystectomy; diet, medical nutrition; nutritional support; functional foods, probiotics, prebiotics
Funding. This manuscript was prepared with financial support of the Ministry of Science and Higher Education of Russia (No. FGMF-2022-0005).
Conflict of interest. The authors declare no conflict of interest.
For citation: Morozov S.V. Medical nutrition after cholecystectomy. Voprosy pitaniia [Problems of Nutrition]. 2024; 93 (2): 73–82. DOI: https://doi.org/10.33029/0042-8833-2024-93-2-73-82 (in Russian)
References
1. Stinton L.M., Myers R.P., Shaffer E.A. Epidemiology of gallstones. Gastroenterol Clin North Am. 2010; 39 (2): 157–69, vii. DOI: https://doi.org/10.1016/j.gtc.2010.02.003
2. Ke B., Sun Y., Dai X., Gui Y., Chen S. Relationship between weight-adjusted waist circumference index and prevalence of gallstones in U.S. adults: a study based on the NHANES 2017-2020. Front Endocrinol (Lausanne). 2023; 14: 1276465. DOI: https://doi.org/10.3389/fendo.2023.1276465
3. Lammert F., Gurusamy K., Ko C.W., Miquel J.F., Méndez-Sánchez N., Portincasa P., et al. Gallstones. Nat Rev Dis Primers. 2016; 2: 16024. DOI: https://doi.org/10.1038/nrdp.2016.24
4. Pisano M., Ceresoli M., Cimbanassi S., Gurusamy K., Coccolini F., Borzellino G., et al. 2017 WSES and SICG guidelines on acute calcolous cholecystitis in elderly population. World J Emerg Surg. 2019; 14: 10. DOI: https://doi.org/10.1186/s13017-019-0224-7
5. Pisano M., Allievi N., Gurusamy K., Borzellino G., Cimbanassi S., Boerna D., et al. 2020 World Society of Emergency Surgery updated guidelines for the diagnosis and treatment of acute calculus cholecystitis. World J Emerg Surg. 2020; 15 (1): 61. DOI: https://doi.org/10.1186/s13017-020-00336-x
6. Cianci P., Restini E. Management of cholelithiasis with choledocholithiasis: endoscopic and surgical approaches. World J Gastroenterol. 2021; 27 (28): 4536–54. DOI: https://doi.org/10.3748/wjg.v27.i28.4536
7. Shaffer E.A. Gallstone disease: epidemiology of gallbladder stone disease. Best Pract Res Clin Gastroenterol. 2006; 20 (6): 981–96. DOI: https://doi.org/10.1016/j.bpg.2006.05.004
8. Peery A.F., Crockett S.D., Murphy C.C., Lund J.L., Dellon E.S., Williams J.L., et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2018. Gastroenterology. 2019; 156 (1): 254–72.e11. DOI: https://doi.org/10.1053/j.gastro.2018.08.063 Erratum in: Gastroenterology. 2019; 156 (6): 1936. PMID: 30315778; PMCID: PMC6689327.
9. Jaunoo S.S., Mohandas S., Almond L.M. Postcholecystectomy syndrome (PCS). Int J Surg. 2010; 8 (1): 15–7. DOI: https://doi.org/10.1016/j.ijsu.2009.10.008
10. Saleem S., Weissman S., Gonzalez H., Rojas P.G., Inayat F., Alshati A., Gaduputi V. Post-cholecystectomy syndrome: a retrospective study analysing the associated demographics, aetiology, and healthcare utilization. Transl Gastroenterol Hepatol. 2021; 6: 58. DOI: https://doi.org/10.21037/tgh.2019.11.08
11. Kim H., Han I.W., Heo J.S., Oh M.G., Lim C.Y., Choi Y.S., et al. Postcholecystectomy syndrome: symptom clusters after laparoscopic cholecystectomy. Ann Surg Treat Res. 2018; 95 (3): 135–40. DOI: https://doi.org/10.4174/astr.2018.95.3.135
12. Altomare D.F., Rotelli M.T., Palasciano N. Diet after cholecystectomy. Curr Med Chem. 2019; 26 (19): 3662–5. DOI: https://doi.org/10.2174/0929867324666170518100053
13. Latenstein C.S.S., Wennmacker S.Z., de Jong J.J., van Laarhoven C.J.H.M., Drenth J.P.H., de Reuver P.R. Etiologies of long-term postcholecystectomy symptoms: a systematic review. Gastroenterol Res Pract. 2019; 2019: 4278373. DOI: https://doi.org/10.1155/2019/4278373
14. Isherwood J., Oakland K., Khanna A. A systematic review of the aetiology and management of post cholecystectomy syndrome. Surgeon. 2019; 17 (1): 33–42. DOI: https://doi.org/10.1016/j.surge.2018.04.001
15. Shabanzadeh D.M. The symptomatic outcomes of cholecystectomy for gallstones. J Clin Med. 2023; 12 (5): 1897. DOI: https://doi.org/10.3390/jcm12051897
16. Fujita N., Yasuda I., Endo I., Isayama H., Iwashita T., Ueki T., et al. Evidence-based clinical practice guidelines for cholelithiasis 2021. J Gastroenterol. 2023; 58 (9): 801–833. DOI: https://doi.org/10.1007/s00535-023-02014-6
17. Kwak M.S., Kim D., Chung G.E., Kim W., Kim Y.J., Yoon J.H. Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population. World J Gastroenterol. 2015; 21: 6287–95. DOI: https://doi.org/10.3748/wjg.v21.i20.6287
18. Kichloo A., Solanki S., Haq K.F., Dahiya D., Bailey B., Solanki D., et al. Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population. World J Gastrointest Pathophysiol. 2021; 12 (2): 14–24. DOI: https://doi.org/10.4291/wjgp.v12.i2.14
19. Chen C.H., Lin C.L., Kao C.H. The effect of cholecystectomy on the risk of colorectal cancer in patients with gallbladder stones. Cancers (Basel). 2020; 12 (3): 550. DOI: https://doi.org/10.3390/cancers12030550
20. Dong Z., Shi R., Li P., Song X., Dong F., Zhu J., et al. Does postcholecystectomy increase the risk of colorectal cancer? Front Microbiol. 2023; 14: 1194419. DOI: https://doi.org/10.3389/fmicb.2023.1194419
21. Shabanzadeh D.M., Skaaby T., Sorensen L.T., Jorgensen T. Screen-detected gallstone disease and cardiovascular disease. Eur J Epidemiol. 2017; 32 (6): 501–10. DOI: https://doi.org/10.1007/s10654-017-0263-x
22. Fu Q., Shen T., Yu Q., Jiang L., Yang R. Causal effect of gallstone disease on the risk of coronary heart disease or acute myocardial infarction: a Mendelian randomization study. Sci Rep. 2023; 13 (1): 18807. DOI: https://doi.org/10.1038/s41598-023-46117-9
23. Di Ciaula A., Garruti G., Wang D.Q., Portincasa P. Cholecystectomy and risk of metabolic syndrome. Eur J Intern Med. 2018; 53: 3–11. DOI: https://doi.org/10.1016/j.ejim.2018.04.019
24. Park S., Jeong S., Park S.J., Song J., Kim S.M., Chang J., et al. Associations of cholecystectomy with metabolic health changes and incident cardiovascular disease: a retrospective cohort study. Sci Rep. 2024; 14 (1): 3195. DOI: https://doi.org/10.1038/s41598-024-53161-6
25. Mahfouz M.E.M., Altowairqi A.D.M., Alghamdi H.Y., Alzahrani M.S.Z., Alqurashi A.K., Alhuraity T.H., et al. Prevalence and factors associated with post-cholecystectomy syndrome in Saudi Arabia. Cureus. 2022; 14 (12): e32827 DOI: https://doi.org/10.7759/cureus.32827
26. Krause’s Food & The Nutrition Care Process. 13th ed. Elsevier, Saunders, 2012: 1227 p. ISBN: 978-1-4377-233-8.
27. Smolyansky B.L., Liflyandsky V.G. Dietetics. The latest reference book for doctors. Saint Petersburg: Sova; Moscow: Eksmo, 2003: 816 p. (in Russian)
28. Nutritionology and Clinical Dietology: national guidelines / ed. V.A. Tutelyan, D.B. Nikityuk. Moscow: GEOTAR-Media, 2020: 656 p. DOI: https://doi.org/10.33029/9704-5352-0-NKD-2020-1-656 (in Russian)
29. Isakov V.A., Morozov S.V., Pilipenko V.I. Chapter 16. Therapeutic nutrition for diseases of the hepato-biliary system and pancreas // Nutrition and Clinical Dietology: national guide / ed. V.A. Tutelyan, D.B. Nikityuk. Moscow: GEOTAR-Media, 2020: 415–35. DOI: https://doi.org/10.33029/9704-5352-0-NKD-2020-1-656 (in Russian)
30. de Menezes H.L., Fireman P.A., Wanderley V.E., de Menconça A.M., Bispo R.K., Reis M.R. Randomized study for assessment of hypolipidic diet in digestive symptoms immediately following laparoscopic cholecystectomy. Rev Col Bras Cir. 2013; 40 (3): 203–7. [English, Portuguese]. DOI: https://doi.org/10.1590/s0100-69912013000300007
31. Yueh T.P., Chen F.Y., Lin T.E., Chuang M.T. Diarrhea after laparoscopic cholecystectomy: associated factors and predictors. Asian J Surg. 2014; 37 (4): 171–7. DOI: https://doi.org/10.1016/j.asjsur.2014.01.008
32. Fisher M., Spilias D.C., Tong L.K. Diarrhoea after laparoscopic cholecystectomy: incidence and main determinants. ANZ J Surg. 2008; 78 (6): 482–6. DOI: https://doi.org/10.1111/j.1445-2197.2008.04539.x
33. Ribas Blasco Y., Pérez Muñante M., Gómez-Fernández L., Jovell-Fernández E., Oms Bernad L.M. Low-fat diet after cholecystectomy: Should it be systematically recommended? Cir Esp (Engl Ed). 2020; 98 (1): 36–42. [English, Spanish]. DOI: https://doi.org/10.1016/j.ciresp.2019.05.009
34. Kullak-Ublick G.A., Paumgartner G., Berr F. Long-term effects of cholecystectomy on bile acid metabolism. Hepatology. 1995; 21: 41–5. DOI: https://doi.org/10.1002/hep.1840210109
35. Reddy B.S., Mangat S., Sheinfil A., Weisburger J.H., Wynder E.L. Effect of type and amount of dietary fat and 1,2-dimethylhydrazine on biliary bile acids, fecal bile acids, and neutral sterols in rats. Cancer Res. 1977; 37 (7 Pt 1): 2132–7. PMID: 861940.
36. Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 2003; 72: 137–74. DOI: https://doi.org/10.1146/annurev.biochem.72.121801.161712
37. Chiang J.Y. Bile acids: regulation of synthesis. J Lipid Res. 2009; 50 (10): 1955–66. DOI: https://doi.org/10.1194/jlr.R900010-JLR200
38. Hearing S.D., Thomas L.A., Heaton K.W., Hunt L. Effect of cholecystectomy on bowel function: a prospective, controlled study. Gut. 1999; 45: 889–94. DOI: https://doi.org/10.1136/gut.45.6.889
39. Xu F., Yu Z., Liu Y., Du T., Yu L., Tian F., et al. A high-fat, high-cholesterol diet promotes intestinal inflammation by exacerbating gut microbiome dysbiosis and bile acid disorders in cholecystectomy. Nutrients. 2023; 15 (17): 3829. DOI: https://doi.org/10.3390/nu15173829
40. Shin Y., Choi D., Lee K.G., Choi H.S., Park Y. Association between dietary intake and postlaparoscopic cholecystectomic symptoms in patients with gallbladder disease. Korean J Intern Med. 2018; 33 (4): 829–36. DOI: https://doi.org/10.3904/kjim.2016.223
41. Ginter E. Cholesterol: vitamin C controls its transformation to bile acids. Science. 1973; 179 (4074): 702–4. DOI: https://doi.org/10.1126/science.179.4074.702
42. Gustafsson U., Wang F.H., Axelson M., Kallner A., Sahlin S., Einarsson K. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time. Eur J Clin Invest. 1997; 27 (5): 387–91. DOI: https://doi.org/10.1046/j.1365-2362.1997.1240670.x
43. Pilipenko V.I., Isakov V.A., Vlasova A.V., Lantseva M.A., Morozov S.V. Association of thermal food processing methods and small intestinal bacterial overgrowth syndrome. Voprosy pitaniia [Problems of Nutrition]. 2020; 89 (3): 106–13. DOI: https://doi.org/10.24411/0042-8833-2020-10034 (in Russian)
44. Jacquier E.F., van de Wouw M., Nekrasov E., Contractor N., Kassis A., Marcu D. Local and systemic effects of bioactive food ingredients: is there a role for functional foods to prime the gut for resilience? Foods. 2024; 13 (5): 739. DOI: https://doi.org/10.3390/foods13050739
45. Yoon W.J., Kim H.N., Park E., Ryu S., Chang Y., Shin H., et al. The impact of cholecystectomy on the gut microbiota: a case-control study. J Clin Med. 2019; 8 (1): 79. DOI: https://doi.org/10.3390/jcm8010079
46. Tian Y., Gui W., Koo I., Smith P.B., Allman E.L., Nichols R.G., et al. The microbiome modulating activity of bile acids. Gut Microbes. 2020; 11: 979–96. DOI: https://doi.org/10.1080/19490976.2020.1732268
47. Wei B., Wang Y., Xiang S., Jiang Y., Chen R., Hu N. Alterations of gut microbiome in patients with type 2 diabetes mellitus who had undergone cholecystectomy. Am J Physiol Endocrinol Metab. 2021; 320 (1): E113–21. DOI: https://doi.org/10.1152/ajpendo.00471.2020
48. Wahlstrom A., Sayin S.I., Marschall H.U., Backhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016; 24: 41–50. DOI: https://doi.org/10.1016/j.cmet.2016.05.005
49. Li Y.D., Liu B.N., Zhao S.H., Zhou Y.L., Bai L., Liu E.Q. Changes in gut microbiota composition and diversity associated with post-cholecystectomy diarrhea. World J Gastroenterol. 2021; 27 (5): 391–403. DOI: https://doi.org/10.3748/wjg.v27.i5.391
50. Xu Y., Jing H., Wang J., Zhang S., Chang Q., Li Z., et al. Disordered gut microbiota correlates with altered fecal bile acid metabolism and post-cholecystectomy diarrhea. Front Microbiol. 2022; 13: 800604. DOI: https://doi.org/10.3389/fmicb.2022.800604
51. Noh C.K., Jung W., Yang M.J., Kim W.H., Hwang J.C. Alteration of the fecal microbiome in patients with cholecystectomy: potential relationship with postcholecystectomy diarrhea – before and after study. Int J Surg. 2023; 109 (9): 2585–97. DOI: https://doi.org/10.1097/JS9.0000000000000518
52. Ye J., Hu Y., Li K. A commentary on «Alteration of the fecal microbiome in patients with cholecystectomy: potential relationship with postcholecystectomy diarrhea – before and after study». Int J Surg. 2024; 110 (2): 1281–2. DOI: https://doi.org/10.1097/JS9.0000000000000870
53. Sarashina-Kida H., Negishi H., Nishio J., Suda W., Nakajima Y., Yasui-Kato M., et al. Gallbladder-derived surfactant protein D regulates gut commensal bacteria for maintaining intestinal homeostasis. Proc Natl Acad Sci USA. 2017; 114 (38): 10 178–83. DOI: https://doi.org/10.1073/pnas.1712837114
54. PLoS One Editors. Expression of concern: cholecystectomy can increase the risk of colorectal cancer: a meta-analysis of 10 cohort studies. PLoS One. 2024; 19 (3): e0300484. DOI: https://doi.org/10.1371/journal.pone.0300484
55. Zhang Y., Liu H., Li L., Ai M., Gong Z., He Y., et al. Cholecystectomy can increase the risk of colorectal cancer: a meta-analysis of 10 cohort studies. PLoS One. 2017; 12 (8): e0181852. DOI: https://doi.org/10.1371/journal.pone.0181852 PMID: 28771518; PMCID: PMC5542607.
56. Mu L., Li W., Ren W., Hu D., Song Y. The association between cholecystectomy and the risk of colorectal cancer: an updated systematic review and meta-analysis of cohort studies. Transl Cancer Res. 2023; 12 (6): 1452–65. DOI: https://doi.org/10.21037/tcr-22-2049
57. Slouha E., Biput S.J., Kuteyi A., Kalloo A.E., Gorantla V.R. Non-alcoholic fatty liver disease and gallstones: a systematic review. Cureus. 2023; 15 (9): e45027. DOI: https://doi.org/10.7759/cureus.45027
58. Pal S.C., Castillo-Castañeda S.M., Díaz-Orozco L.E., RamírezMejía M.M., Dorantes-Heredia R., Alonso-Morales R., et al. Molecular mechanisms involved in MAFLD in cholecystectomized patients: a cohort study. Genes (Basel). 2023; 14 (10): 1935. DOI: https://doi.org/10.3390/genes14101935
59. Cai J., Sun L., Gonzalez F.J. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. Cell Host Microbe. 2022; 30: 289–300. DOI: https://doi.org/10.1016/j.chom.2022.02.004
60. Fu T., Coulter S., Yoshihara E., Oh T.G., Fang S., Cayabyab F., et al. FXR regulates intestinal cancer stem cell proliferation. Cell. 2019; 176: 1098–112. DOI: https://doi.org/10.1016/j.cell.2019.01.036
61. Makki K., Deehan E.C., Walter J., Backhed F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018; 23: 705–15. DOI: https://doi.org/10.1016/j.chom.2018.05.012
62. Dalile B., Van Oudenhove L., Vervliet B., Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol. 2019; 16: 461–78. DOI: https://doi.org/10.1038/s41575-019-0157-3
63. Qi X., Tester R.F. Utilisation of dietary fibre (non-starch polysaccharide and resistant starch) molecules for diarrhoea therapy: a mini-review. Int J Biol Macromol. 2019; 122: 572–7. DOI: https://doi.org/10.1016/j.ijbiomac.2018.10.195
64. Xu T., Wu X., Liu J., Sun J., Wang X., Fan G., et al. The regulatory roles of dietary fibers on host health via gut microbiota-derived short chain fatty acids. Curr Opin Pharmacol. 2022; 62: 36–42. DOI: https://doi.org/10.1016/j.coph.2021.11.001
65. Waitzberg D., Guarner F., Hojsak I., Ianiro G., Polk D.B., Sokol H. Can the evidence-based use of probiotics (notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) mitigate the clinical effects of antibiotic-associated dysbiosis? Adv Ther. 2024; 41 (3): 901–14. DOI: https://doi.org/10.1007/s12325-024-02783-3
66. Huang R.L., Huang W.K., Xiao X.Y., Ma L.F., Gu H.Z., Yang G.P. Diagnosis and treatment of post-cholecystectomy diarrhoea. World J Gastrointest Surg. 2023; 15 (11): 2398–405. DOI: https://doi.org/10.4240/wjgs.v15.i11.2398
67. Cui B., Lin L., Wang B., Liu W., Sun C. Therapeutic potential of Saccharomyces boulardii in liver diseases: from passive bystander to protective performer? Pharmacol Res. 2022; 175: 106022. DOI: https://doi.org/10.1016/j.phrs.2021.106022
68. Fernández-Alonso M., Aguirre Camorlinga A., Messiah S.E., Marroquin E. Effect of adding probiotics to an antibiotic intervention on the human gut microbial diversity and composition: a systematic review. J Med Microbiol. 2022; 71 (11). DOI: https://doi.org/10.1099/jmm.0.001625
69. Polat H.B., Beyazal M.S. The effect of cholecystectomy on 25-hydroxyvitamin D levels and bone mineral density in postmenopausal women. Arch Osteoporos. 2018; 13 (1): 61. DOI: https://doi.org/10.1007/s11657-018-0458-0
70. Ekiz T., Yeğen S.F., Katar M.K., Genç Ö., Genç S. 25-Hydroxyvitamin D levels and bone mineral density evaluation in patients with cholecystectomy: a case-control study. Arch Osteoporos. 2018; 13 (1): 14. DOI: https://doi.org/10.1007/s11657-018-0435-7
71. Lee E.J., Shin C.M., Lee D.H., Han K., Park S.H., Kim Y.J., et al. The association between cholecystectomy and the risk for fracture: A nationwide population-based cohort study in Korea. Front Endocrinol (Lausanne). 2021; 12: 657488. DOI: https://doi.org/10.3389/fendo.2021.657488
72. Doğan D., Çelik T. Research trends on the gut microbiota in endocrine metabolism: a thematic and bibliometric analysis. Front Cell Infect Microbiol. 2024; 14: 1371727. DOI: https://doi.org/10.3389/fcimb.2024.1371727
73. Hu X., Yu C., He Y., Zhu S., Wang S., Xu Z., et al. Integrative metagenomic analysis reveals distinct gut microbial signatures related to obesity. BMC Microbiol. 2024; 24 (1): 119. DOI: https://doi.org/10.1186/s12866-024-03278-5
74. Li Y., Wang X., Zhang Z., Shi L., Cheng L., Zhang X. Effect of the gut microbiome, plasma metabolome, peripheral cells, and inflammatory cytokines on obesity: a bidirectional two-sample Mendelian randomization study and mediation analysis. Front Immunol. 2024; 15: 1348347. DOI: https://doi.org/10.3389/fimmu.2024.1348347
75. Ali R.B., Cahill R.A., Watson R.G. Weight gain after laparoscopic cholecystectomy. Ir J Med Sci. 2004; 173 (1): 9–12. DOI: https://doi.org/10.1007/BF02914515
76. Stokes C.S., Lammert F. Excess body weight and gallstone disease. Visc Med. 2021; 37 (4): 254–60. DOI: https://doi.org/10.1159/000516418
77. Marcason W. What medical nutrition therapy guideline is recommended post-cholecystectomy? J Acad Nutr Diet. 2014; 114 (7): 1136. DOI: https://doi.org/10.1016/j.jand.2014.05.009
78. European Association for the Study of the Liver (EASL). EASL clinical practice guidelines on the prevention, diagnosis and treatment of gallstones. J Hepatol. 2016; 65 (1): 146–81. DOI: https://doi.org/10.1016/j.jhep.2016.03.005
79. Zhang Y., Peng J., Li X., Liao M. Endoscopic-laparoscopic cholecystolithotomy in treatment of cholecystolithiasis compared with traditional laparoscopic cholecystectomy. Surg Laparosc Endosc Percutan Tech. 2016; 26 (5): 377–80. DOI: https://doi.org/10.1097/SLE.0000000000000305
80. Javed A., Shashikiran B.D., Aravinda P.S., Agarwal A.K. Laparoscopic versus open surgery for the management of post-cholecystectomy benign biliary strictures. Surg Endosc. 2021; 35 (3): 1254–63. DOI: https://doi.org/10.1007/s00464-020-07496-6
81. Alexander H.C., Nguyen C.H., Moore M.R., Bartlett A.S., Hannam J.A., Poole G.H., et al. Measurement of patient-reported outcomes after laparoscopic cholecystectomy: a systematic review. Surg Endosc. 2019; 33 (7): 2061–71. DOI: https://doi.org/10.1007/s00464-019-06745-7
82. Glasgow R.E., Mulvihill S.J. Treatment of gallstone disease. In: M. Feldman, L.S. Friedman, L.J. Brandt (eds). Sleisenger and Fordtran’s Gastrointestional and Liver Disease. 9th ed. Vol. 1. Philadelphia, PA : Saunders, 2010: 1121–38.
83. Chang J.Y., Jung H.K., Moon C.M., Kim S.E., Shim K.N., Jung S.A., et al. Development of functional gastrointestinal disorder symptoms following laparoscopic cholecystectomy: a prospective cohort study. Front Med (Lausanne). 2023; 10: 1248465. DOI: https://doi.org/10.3389/fmed.2023.1248465